These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 33145014)
21. Study on the relationship between CXCR3 and its ligands and tubal tuberculosis. Sun H; Fan J; Shang X; Tuohetaerbaike B; Li Y; Lv J; Wang Y; Wang L; Wang J; Ma X Life Sci; 2021 May; 272():119047. PubMed ID: 33454369 [TBL] [Abstract][Full Text] [Related]
22. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. Flier J; Boorsma DM; van Beek PJ; Nieboer C; Stoof TJ; Willemze R; Tensen CP J Pathol; 2001 Aug; 194(4):398-405. PubMed ID: 11523046 [TBL] [Abstract][Full Text] [Related]
24. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment. Reynders N; Abboud D; Baragli A; Noman MZ; Rogister B; Niclou SP; Heveker N; Janji B; Hanson J; Szpakowska M; Chevigné A Cells; 2019 Jun; 8(6):. PubMed ID: 31216755 [TBL] [Abstract][Full Text] [Related]
25. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis. Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722 [TBL] [Abstract][Full Text] [Related]
26. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4 Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q Front Immunol; 2018; 9():2932. PubMed ID: 30619292 [TBL] [Abstract][Full Text] [Related]
27. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4 Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509 [TBL] [Abstract][Full Text] [Related]
28. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum. Müller M; Carter S; Hofer MJ; Campbell IL Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305 [TBL] [Abstract][Full Text] [Related]
29. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration. Koper OM; Kamińska J; Sawicki K; Kemona H Adv Clin Exp Med; 2018 Jun; 27(6):849-856. PubMed ID: 29893515 [TBL] [Abstract][Full Text] [Related]
30. The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts. Kouroumalis A; Nibbs RJ; Aptel H; Wright KL; Kolios G; Ward SG J Immunol; 2005 Oct; 175(8):5403-11. PubMed ID: 16210647 [TBL] [Abstract][Full Text] [Related]
31. Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease. Bondar C; Araya RE; Guzman L; Rua EC; Chopita N; Chirdo FG PLoS One; 2014; 9(2):e89068. PubMed ID: 24586509 [TBL] [Abstract][Full Text] [Related]
32. Targeting CXCL9/10/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity. Pan M; Wei X; Xiang X; Liu Y; Zhou Q; Yang W Clin Transl Oncol; 2023 Aug; 25(8):2306-2320. PubMed ID: 37076663 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110 [TBL] [Abstract][Full Text] [Related]
34. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015 [TBL] [Abstract][Full Text] [Related]
35. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530 [TBL] [Abstract][Full Text] [Related]
36. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Zeremski M; Petrovic LM; Chiriboga L; Brown QB; Yee HT; Kinkhabwala M; Jacobson IM; Dimova R; Markatou M; Talal AH Hepatology; 2008 Nov; 48(5):1440-50. PubMed ID: 18798334 [TBL] [Abstract][Full Text] [Related]
37. Cloning, expression and characterization of ferret CXCL10. Danesh A; Seneviratne C; Cameron CM; Banner D; Devries ME; Kelvin AA; Xu L; Ran L; Bosinger SE; Rowe T; Czub M; Jonsson CB; Cameron MJ; Kelvin DJ Mol Immunol; 2008 Mar; 45(5):1288-97. PubMed ID: 18006061 [TBL] [Abstract][Full Text] [Related]
38. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. Menke J; Zeller GC; Kikawada E; Means TK; Huang XR; Lan HY; Lu B; Farber J; Luster AD; Kelley VR J Am Soc Nephrol; 2008 Jun; 19(6):1177-89. PubMed ID: 18337479 [TBL] [Abstract][Full Text] [Related]
39. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Costa C; Rufino R; Traves SL; Lapa E Silva JR; Barnes PJ; Donnelly LE Chest; 2008 Jan; 133(1):26-33. PubMed ID: 17925429 [TBL] [Abstract][Full Text] [Related]
40. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines. Shin SY; Nam JS; Lim Y; Lee YH J Biol Chem; 2010 Oct; 285(40):30731-40. PubMed ID: 20650898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]